LivaNova Quarterly Balance Sheet
NASDAQ: LIVNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LivaNova financial position
As of Jun 30, 2026, LivaNova reported total assets of $2.64 billion, up 5.4% from a year earlier against total liabilities of $1.32 billion. Shareholders' equity stood at $1.33 billion, or 50.2% of assets. The company held $516.6 million in cash and equivalents against $293.5 million of debt, a net cash position of $223.1 million.
The current ratio (current assets divided by current liabilities) was 1.45, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.22.
Summary generated from market data by MetaCap's automated system. Methodology
LivaNova balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 516.62M | 539.71M | 635.55M | 646.08M | 593.64M | 738.44M | 428.86M | 346.37M | 329.24M | 309.19M | 266.50M | 233.94M |
| Receivables | 231.30M | 229.27M | 215.99M | 211.58M | 220.19M | 202.08M | 193.16M | 197.16M | 200.89M | 209.43M | 215.07M | 189.87M |
| Inventory | 172.61M | 165.50M | 164.70M | 167.54M | 165.35M | 154.02M | 147.57M | 162.26M | 154.72M | 153.18M | 147.89M | 161.54M |
| Total Current Assets | 1.03B | 1.01B | 1.10B | 1.10B | 1.07B | 1.17B | 1.13B | 1.09B | 1.05B | 1.04B | 988.16M | 953.87M |
| Property, Plant & Equipment | 273.33M | 255.48M | 242.60M | 218.51M | 195.42M | 177.68M | 170.26M | 169.32M | 158.06M | 152.24M | 154.18M | 149.30M |
| Goodwill | 779.14M | 785.59M | 792.84M | 791.03M | 793.37M | 761.91M | 750.01M | 781.55M | 766.37M | 771.82M | 782.94M | 767.05M |
| Intangible Assets | 217.00M | 224.56M | 229.96M | 234.53M | 239.14M | 236.59M | 237.29M | 248.54M | 248.19M | 253.93M | 261.18M | 347.67M |
| Long-Term Investments | 15.27M | 18.49M | 20.29M | — | — | — | 25.08M | — | — | — | — | — |
| Total Assets | 2.64B | 2.52B | 2.61B | 2.56B | 2.51B | 2.56B | 2.51B | 2.52B | 2.45B | 2.46B | 2.43B | 2.33B |
| Accounts Payable | 103.39M | 99.15M | 97.16M | 88.16M | 86.93M | 87.64M | 69.73M | 77.89M | 81.32M | 75.94M | 80.84M | 62.78M |
| Short-Term Debt | 3.58M | 2.63M | 31.47M | 85.44M | 82.13M | 79.57M | 78.00M | 21.95M | 19.74M | 19.70M | 18.11M | 19.03M |
| Total Current Liabilities | 707.00M | 762.48M | 808.07M | 827.59M | 827.10M | 741.57M | 392.13M | 324.40M | 302.99M | 327.77M | 334.98M | 295.40M |
| Long-Term Debt | 289.91M | 285.16M | 345.19M | 349.03M | 348.49M | 549.22M | 549.62M | 604.29M | 605.43M | 604.75M | 568.54M | 568.16M |
| Total Liabilities | 1.32B | 1.31B | 1.41B | 1.40B | 1.38B | 1.52B | 1.19B | 1.21B | 1.21B | 1.24B | 1.15B | 1.10B |
| Shareholders' Equity | 1.33B | 1.21B | 1.20B | 1.16B | 1.12B | 1.03B | 1.32B | 1.31B | 1.24B | 1.22B | 1.28B | 1.23B |
| Retained Earnings | -1.01B | -1.12B | -1.15B | -1.18B | -1.20B | -1.23B | -903.25M | -959.14M | -992.09M | -1.01B | -966.48M | -982.82M |
| Total Debt | 293.49M | 287.79M | 376.66M | 434.47M | 430.62M | 628.79M | 627.63M | 626.24M | 625.17M | 624.46M | 586.65M | 587.19M |
| Net Cash (Debt) | 223.13M | 251.92M | 258.89M | 211.61M | 163.02M | 109.64M | -198.77M | -279.87M | -295.94M | -315.27M | -320.15M | -353.25M |
| Shares Outstanding | 55.05M | 54.90M | 54.65M | 54.61M | 54.59M | 54.52M | 54.35M | 54.30M | 54.30M | 54.15M | 53.92M | 53.86M |
This table shows 12 quarterly periods of LivaNova's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow LIVN's reporting calendar. What is a balance sheet?